AAAAAA

   
Results: 1-25 |
Results: 25
CLONING OF A HUMAN CANCER CELL-LINE (NSCLC-N6) AND COMPARATIVE-STUDY OF THE CLONES IN-VITRO
Authors: SIAVOSHIAN S BOESCH S PONDAVEN P MORE M RIOU D DABOUIS G ANDRE MJ ROUSSAKIS C
Citation: S. Siavoshian et al., CLONING OF A HUMAN CANCER CELL-LINE (NSCLC-N6) AND COMPARATIVE-STUDY OF THE CLONES IN-VITRO, Anticancer research, 18(1A), 1998, pp. 193-200
INTERIM RESULTS OF A PHASE-II STUDY OF DOCETAXEL (TAXOTERE(R)) IN UNRESECTABLE NONSMALL CELL LUNG-CANCER (NSCLC) ON 204 CHEMOTHERAPY NAIVE OR PRETREATED PATIENTS
Authors: MATTSON K LECHEVALIER T BOSQUEE L PUJOL JL CULINE S DABOUIS G LEGROUMELLEC A STUPP R BOYER R BERILLE J
Citation: K. Mattson et al., INTERIM RESULTS OF A PHASE-II STUDY OF DOCETAXEL (TAXOTERE(R)) IN UNRESECTABLE NONSMALL CELL LUNG-CANCER (NSCLC) ON 204 CHEMOTHERAPY NAIVE OR PRETREATED PATIENTS, European journal of cancer, 33, 1997, pp. 1036-1036
RESPONSE TO CHEMOTHERAPY HAS PREDICTIVE VALUE FOR FURTHER SURVIVAL OFPATIENTS WITH ADVANCED NONSMALL CELL LUNG-CANCER - 10 YEARS EXPERIENCE OF THE EUROPEAN LUNG-CANCER WORKING PARTY
Authors: PAESMANS M SCULIER JP LIBERT P BUREAU G DABOUIS G THIRIAUX J MICHEL J VANCUTSEM O SERGYSELS R MOMMEN P KLASTERSKY J
Citation: M. Paesmans et al., RESPONSE TO CHEMOTHERAPY HAS PREDICTIVE VALUE FOR FURTHER SURVIVAL OFPATIENTS WITH ADVANCED NONSMALL CELL LUNG-CANCER - 10 YEARS EXPERIENCE OF THE EUROPEAN LUNG-CANCER WORKING PARTY, European journal of cancer, 33(14), 1997, pp. 2326-2332
THE PROGNOSTIC FACTORS FOR ADVANCED NONSM ALL CELL LUNG-CANCER - THE EXPERIENCE OF THE EUROPEAN LUNG-CANCER WORKING PARTY
Authors: SCULIER JP PAESMANS M LIBERT P BUREAU G DABOUIS G THIRIAUX J MICHEL J VANCUTSEM O SCHMERBER J GINER V BERCHIER MC MOMMEN P SERGYSELS R KLASTERSKY J
Citation: Jp. Sculier et al., THE PROGNOSTIC FACTORS FOR ADVANCED NONSM ALL CELL LUNG-CANCER - THE EXPERIENCE OF THE EUROPEAN LUNG-CANCER WORKING PARTY, Revue des maladies respiratoires, 14(6), 1997, pp. 445-449
CORRELATION BETWEEN MULTIDRUG-RESISTANCE AND THE DEGREE OF DIFFERENTIATION OF NON-SMALL-CELL BRONCHOPULMONARY CARCINOMA (NSCLC) IN-VITRO AND IN-VIVO
Authors: BOSCH S SIAVOSHIAN S JACQUOT C TOMASONI C DABOUIS G ELANBALOUSSI Y LENEEL T MORE M ROUSSAKIS C
Citation: S. Bosch et al., CORRELATION BETWEEN MULTIDRUG-RESISTANCE AND THE DEGREE OF DIFFERENTIATION OF NON-SMALL-CELL BRONCHOPULMONARY CARCINOMA (NSCLC) IN-VITRO AND IN-VIVO, Anticancer research, 17(6D), 1997, pp. 4595-4598
TERMINAL DIFFERENTIATION IN A NON-SMALL-CELL BRONCHOPULMONARY CARCINOMA CORRELATES WITH INCREASED EXPRESSION OF P53
Authors: LISCIA E RIOU D SIAVOSHIAN S BOESCH S LEBERT V TOMASONI C DABOUIS G BIARD JF ROUSSAKIS C
Citation: E. Liscia et al., TERMINAL DIFFERENTIATION IN A NON-SMALL-CELL BRONCHOPULMONARY CARCINOMA CORRELATES WITH INCREASED EXPRESSION OF P53, Anticancer research, 16(3A), 1996, pp. 1209-1212
PROGNOSTIC FACTORS FOR RESPONSE TO CHEMOTHERAPY CONTAINING PLATINUM DERIVATIVES IN PATIENTS WITH UNRESECTABLE NONSMALL CELL LUNG-CANCER (NSCLC)
Authors: BORGES M SCULIER JP PAESMANS M RICHEZ M BUREAU G DABOUIS G LECOMTE J MICHEL J VANCUTSEM O SCHMERBER J GINER V BERCHIER MC SERGYSELS R MOMMEN P KLASTERSKY J
Citation: M. Borges et al., PROGNOSTIC FACTORS FOR RESPONSE TO CHEMOTHERAPY CONTAINING PLATINUM DERIVATIVES IN PATIENTS WITH UNRESECTABLE NONSMALL CELL LUNG-CANCER (NSCLC), Lung cancer, 16(1), 1996, pp. 21-33
PHASE I II STUDY OF GEMCITABINE AND CISPLATIN IN THE TREATMENT OF ADVANCED NONSMALL CELL LUNG-CANCER - PRELIMINARY-RESULTS/
Authors: STEWARD WP DUNLOP DJ DABOUIS G LACROIX H TALBOT D
Citation: Wp. Steward et al., PHASE I II STUDY OF GEMCITABINE AND CISPLATIN IN THE TREATMENT OF ADVANCED NONSMALL CELL LUNG-CANCER - PRELIMINARY-RESULTS/, Seminars in oncology, 23(5), 1996, pp. 43-47
GEMCITABINE COMBINED WITH CISPLATIN IN NON-SMALL-CELL LUNG-CANCER (NSCLC) - A PHASE I II STUDY/
Authors: STEWARD WP DUNLOP DJ CAMERON C TALBOT DC KLEISBAUER JL THOMAS P GUERIN JC PEROL M SANSON C DABOUIS G LACROIX H
Citation: Wp. Steward et al., GEMCITABINE COMBINED WITH CISPLATIN IN NON-SMALL-CELL LUNG-CANCER (NSCLC) - A PHASE I II STUDY/, European journal of cancer, 31A, 1995, pp. 1081-1081
COMBINATION CHEMOTHERAPY WITH GEMCITABINE AND CISPLATIN IN THE TREATMENT OF ADVANCED NON-SMALL-CELL LUNG-CANCER - PRELIMINARY-RESULTS OF ANONGOING PHASE I II STUDY/
Authors: STEWARD WP DUNLOP DJ CAMERON C TALBOT DC KLEISBAUER JP THOMAS P GUERIN JC PEROL M SANSON C DABOUIS G LACROIX H
Citation: Wp. Steward et al., COMBINATION CHEMOTHERAPY WITH GEMCITABINE AND CISPLATIN IN THE TREATMENT OF ADVANCED NON-SMALL-CELL LUNG-CANCER - PRELIMINARY-RESULTS OF ANONGOING PHASE I II STUDY/, Anti-cancer drugs, 6, 1995, pp. 33-37
THE EPIDEMIOLOGY OF MALIGNANT PLEURAL MES OTHELIOMA IN THE NANTES-SAINT-NAZAIRE REGION - EVOLUTION BETWEEN 1956 AND 1992
Authors: CHAILLEUX E PIOCHE D CHOPPRA S DABOUIS G GERMAUD P DELAJARTRE AY DELAJARTRE M
Citation: E. Chailleux et al., THE EPIDEMIOLOGY OF MALIGNANT PLEURAL MES OTHELIOMA IN THE NANTES-SAINT-NAZAIRE REGION - EVOLUTION BETWEEN 1956 AND 1992, Revue des maladies respiratoires, 12(4), 1995, pp. 353-357
PROGNOSTIC FACTORS FOR SURVIVAL IN ADVANCED NON-SMALL-CELL LUNG-CANCER - UNIVARIATE AND MULTIVARIATE ANALYSES INCLUDING RECURSIVE PARTITIONING AND AMALGAMATION ALGORITHMS IN 1,052 PATIENTS
Authors: PAESMANS M SCULIER JP LIBERT P BUREAU G DABOUIS G THIRIAUX J MICHEL J VANCUTSEM O SERGYSELS R MOMMEN P KLASTERSKY J
Citation: M. Paesmans et al., PROGNOSTIC FACTORS FOR SURVIVAL IN ADVANCED NON-SMALL-CELL LUNG-CANCER - UNIVARIATE AND MULTIVARIATE ANALYSES INCLUDING RECURSIVE PARTITIONING AND AMALGAMATION ALGORITHMS IN 1,052 PATIENTS, Journal of clinical oncology, 13(5), 1995, pp. 1221-1230
EFFICACY OF COMBINATION MULTIDRUG CHEMOTH ERAPY (MITOMYCIN, IFOSFAMIDE AND CISPLATIN) AND RADIOTHERAPY FOR TREATMENT OF BRAIN METASTASES INNONSMALL CELL LUNG-CANCER
Authors: CUMIN I LACROIX H MAHE M DUTIN JP DABOUIS G
Citation: I. Cumin et al., EFFICACY OF COMBINATION MULTIDRUG CHEMOTH ERAPY (MITOMYCIN, IFOSFAMIDE AND CISPLATIN) AND RADIOTHERAPY FOR TREATMENT OF BRAIN METASTASES INNONSMALL CELL LUNG-CANCER, Bulletin du cancer, 82(1), 1995, pp. 57-62
LONG-TERM SURVIVAL AFTER CHEMOTHERAPY CONTAINING PLATINUM DERIVATIVESIN PATIENTS WITH ADVANCED UNRESECTABLE NONSMALL CELL LUNG-CANCER
Authors: SCULIER JP PAESMANS M LIBERT P BUREAU G DABOUIS G THIRIAUX J MICHEL J VANCUTSEM O SCHMERBER J GINER V BERCHIER MC SERGYSELS R MOMMEN P KLASTERSKY J
Citation: Jp. Sculier et al., LONG-TERM SURVIVAL AFTER CHEMOTHERAPY CONTAINING PLATINUM DERIVATIVESIN PATIENTS WITH ADVANCED UNRESECTABLE NONSMALL CELL LUNG-CANCER, European journal of cancer, 30A(9), 1994, pp. 1342-1347
A 4-DRUG COMBINATION CHEMOTHERAPY WITH CISPLATIN, MITOMYCIN, VINDESINE AND 5-FLUOROURACIL - A REGIMEN ASSOCIATED WITH MAJOR TOXICITY IN PATIENTS WITH ADVANCED NONSMALL CELL LUNG-CANCER
Authors: KLASTERSKY J SCULIER JP RIES F DABOUIS G LIBERT P SCHMERBER J THIRIAUX J BERCHIER MC BUREAU G VANCUTSEM O TAGNON A SERGYSELS R MOMMEN P PAESMANS M
Citation: J. Klastersky et al., A 4-DRUG COMBINATION CHEMOTHERAPY WITH CISPLATIN, MITOMYCIN, VINDESINE AND 5-FLUOROURACIL - A REGIMEN ASSOCIATED WITH MAJOR TOXICITY IN PATIENTS WITH ADVANCED NONSMALL CELL LUNG-CANCER, Annals of oncology, 5(7), 1994, pp. 641-643
SMALL-CELL LUNG-CANCER - COMPARISON TO A WEEKLY CHEMOTHERAPY WITH DRUGS WITH A STANDARD CHEMOTHERAPY
Authors: SCULIER JP PAESMANS M BUREAU G DABOUIS G LIBERT P VANDERMOTEN G VANCUTSEM O BERCHIER MC RIES F MICHEL J SERGYSELS R MOMMEN P KLASTERSKY J
Citation: Jp. Sculier et al., SMALL-CELL LUNG-CANCER - COMPARISON TO A WEEKLY CHEMOTHERAPY WITH DRUGS WITH A STANDARD CHEMOTHERAPY, Revue des maladies respiratoires, 11(3), 1994, pp. 257-261
PHASE-II RANDOMIZED TRIAL COMPARING HIGH-DOSE CISPLATIN WITH MODERATE-DOSE CISPLATIN AND CARBOPLATIN IN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG-CANCER
Authors: SCULIER JP KLASTERSKY J GINER V BUREAU G THIRIAUX J DABOUIS G EFREMIDIS A RIES F BERCHIER MC SERGYSELS R MOMMEN P PAESMANS M
Citation: Jp. Sculier et al., PHASE-II RANDOMIZED TRIAL COMPARING HIGH-DOSE CISPLATIN WITH MODERATE-DOSE CISPLATIN AND CARBOPLATIN IN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG-CANCER, Journal of clinical oncology, 12(2), 1994, pp. 353-359
EVIDENCE FOR 2 DISTINCT ALPHA(1,2)-FUCOSYL-TRANSFERASE GENES DIFFERENTIALLY EXPRESSED THROUGHOUT THE RAT COLON
Authors: PIAU JP LABARRIERE N DABOUIS G DENIS MG
Citation: Jp. Piau et al., EVIDENCE FOR 2 DISTINCT ALPHA(1,2)-FUCOSYL-TRANSFERASE GENES DIFFERENTIALLY EXPRESSED THROUGHOUT THE RAT COLON, Biochemical journal, 300, 1994, pp. 623-626
A 4-DRUG COMBINATION CHEMOTHERAPY WITH CISPLATIN, MITOMYCIN, VINDESINE AND 5-FLUOROURACIL - A REGIMEN ASSOCIATED WITH MAJOR TOXICITY IN PATIENTS WITH ADVANCED NONSMALL CELL LUNG-CANCER
Authors: KLASTERSKY J SCULIER JP RIES F DABOUIS G LIBERT P SCHMERBER J THIRIAUX J BERCHIER MC BUREAU G VANCUTSEM O TAGNON A SERGYSELS R MOMMEN P PAESMANS M
Citation: J. Klastersky et al., A 4-DRUG COMBINATION CHEMOTHERAPY WITH CISPLATIN, MITOMYCIN, VINDESINE AND 5-FLUOROURACIL - A REGIMEN ASSOCIATED WITH MAJOR TOXICITY IN PATIENTS WITH ADVANCED NONSMALL CELL LUNG-CANCER, Lung cancer, 11(5-6), 1994, pp. 373-384
INTRAPLEURAL TREATMENT WITH RECOMBINANT GAMMA-INTERFERON IN EARLY-STAGE MALIGNANT PLEURAL MESOTHELIOMA
Authors: BOUTIN C NUSSBAUM E MONNET I BIGNON J VANDERSCHUEREN R GUERIN JC MENARD O MIGNOT P DABOUIS G DOUILLARD JY
Citation: C. Boutin et al., INTRAPLEURAL TREATMENT WITH RECOMBINANT GAMMA-INTERFERON IN EARLY-STAGE MALIGNANT PLEURAL MESOTHELIOMA, Cancer, 74(9), 1994, pp. 2460-2467
INTRAPLEURAL TREATMENT WITH RECOMBINANT GAMMA-INTERFERON IN EARLY-STAGE MALIGNANT PLEURAL MESOTHELIOMA
Authors: BOUTIN C NUSSBAUM E MONNET I BIGNON J VANDERSCHUEREN R GUERIN JC MENARD O MIGNOT P DABOUIS G DOUILLARD JY
Citation: C. Boutin et al., INTRAPLEURAL TREATMENT WITH RECOMBINANT GAMMA-INTERFERON IN EARLY-STAGE MALIGNANT PLEURAL MESOTHELIOMA, Cancer, 74(9), 1994, pp. 2460-2467
MULTIPLE-DRUG WEEKLY CHEMOTHERAPY VERSUS STANDARD COMBINATION REGIMENIN SMALL-CELL LUNG-CANCER - A PHASE-III RANDOMIZED STUDY CONDUCTED BYTHE EUROPEAN LUNG-CANCER WORKING PARTY
Authors: SCULIER JP PAESMANS M BUREAU G DABOUIS G LIBERT P VANDERMOTEN G VANCUTSEM O BERCHIER MC RIES F MICHEL J SERGYSELS R MOMMEN P KLASTERSKY J
Citation: Jp. Sculier et al., MULTIPLE-DRUG WEEKLY CHEMOTHERAPY VERSUS STANDARD COMBINATION REGIMENIN SMALL-CELL LUNG-CANCER - A PHASE-III RANDOMIZED STUDY CONDUCTED BYTHE EUROPEAN LUNG-CANCER WORKING PARTY, Journal of clinical oncology, 11(10), 1993, pp. 1858-1865
INVIVO STUDY OF VINORELBINE ASSOCIATIONS WITH CISPLATIN, 5-FLUOROURACIL OR ACTINOMYCIN-D RELATIVE TO A NON-SMALL-CELL LUNG-CARCINOMA (NSCLCN6-L16)
Authors: ROUSSAKIS C POUCHUS YF GRATAS C RIOU D DIMOU P DABOUIS G MERLE S VERBIST JF
Citation: C. Roussakis et al., INVIVO STUDY OF VINORELBINE ASSOCIATIONS WITH CISPLATIN, 5-FLUOROURACIL OR ACTINOMYCIN-D RELATIVE TO A NON-SMALL-CELL LUNG-CARCINOMA (NSCLCN6-L16), Anti-cancer drug design, 8(2), 1993, pp. 165-171
COMPARISON MRI, BONE SCINTIGRAM AND OSTEOMEDULLAR BIOPSY IN THE DETECTION OF BONE METASTASES IN SMALL-CELL LUNG-CANCER
Authors: BUHE T KERJAN A FICHE M BIZAIS Y RESCHE I DABOUIS G CROCHET D
Citation: T. Buhe et al., COMPARISON MRI, BONE SCINTIGRAM AND OSTEOMEDULLAR BIOPSY IN THE DETECTION OF BONE METASTASES IN SMALL-CELL LUNG-CANCER, The American review of respiratory disease, 147(4), 1993, pp. 526-526
CORRELATION BETWEEN HIGH-RESOLUTION COMPUTED-TOMOGRAPHY ASSESSMENT OFINTERSTITIAL LESIONS AND PULMONARY-FUNCTION TESTS IN ASBESTOSIS
Authors: BUHE T KERJAN A LINDER F CHAILLEUX E DABOUIS G DELUMEAU J CROCHET D
Citation: T. Buhe et al., CORRELATION BETWEEN HIGH-RESOLUTION COMPUTED-TOMOGRAPHY ASSESSMENT OFINTERSTITIAL LESIONS AND PULMONARY-FUNCTION TESTS IN ASBESTOSIS, The American review of respiratory disease, 147(4), 1993, pp. 905-905
Risultati: 1-25 |